Diya joined Abingworth in June 2021 from L.E.K. Consulting. She works with our transatlantic investment team, in particular the Clinical Co-Development team, to evaluate new investment opportunities and to support existing investments.
As a Consultant with L.E.K. Consulting’s Life Sciences practice, Diya advised pharmaceutical, biotech and early and late-stage buyside clients on a range of projects including corporate strategy, and clinical and commercial opportunity assessments.
Diya holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.
